Bausch Health Cos Retained Earnings (Accumulated Deficit) 2010-2024 | BHC

Bausch Health Cos retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Bausch Health Cos Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-9,778
2022 $-9,186
2021 $-8,961
2020 $-8,013
2019 $-7,452
2018 $-5,664
2017 $-2,725
2016 $-5,129
2015 $-2,750
2014 $-2,398
2013 $-3,279
2012 $-2,371
2011 $-2,030
2010 $-935
2009 $-246
Bausch Health Cos Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-9,917
2024-06-30 $-9,832
2024-03-31 $-9,842
2023-12-31 $-9,778
2023-09-30 $-9,739
2023-06-30 $-9,361
2023-03-31 $-9,387
2022-12-31 $-9,186
2022-09-30 $-8,776
2022-06-30 $-9,175
2022-03-31 $-9,030
2021-12-31 $-8,961
2021-09-30 $-9,030
2021-06-30 $-9,218
2021-03-31 $-8,623
2020-12-31 $-8,013
2020-09-30 $-7,860
2020-06-30 $-7,931
2020-03-31 $-7,605
2019-12-31 $-7,452
2019-09-30 $-5,936
2019-06-30 $-5,887
2019-03-31 $-5,716
2018-12-31 $-5,664
2018-09-30 $-5,320
2018-06-30 $-4,970
2018-03-31 $-4,209
2017-12-31 $-2,725
2017-09-30 $-3,239
2017-06-30 $-4,539
2017-03-31 $-4,502
2016-12-31 $-5,129
2016-09-30 $-4,614
2016-06-30 $-3,426
2016-03-31 $-3,123
2015-12-31 $-2,750
2015-09-30 $-2,339
2015-06-30 $-2,388
2015-03-31 $-2,291
2014-12-31 $-2,398
2014-09-30 $-2,900
2014-06-30 $-3,175
2014-03-31 $-3,301
2013-12-31 $-3,279
2013-09-30 $-3,402
2013-06-30 $-2,429
2013-03-31 $-2,424
2012-12-31 $-2,371
2012-09-30 $-2,282
2012-06-30 $-2,246
2012-03-31 $-2,116
2011-12-31 $-2,030
2011-09-30 $-2,056
2011-06-30 $-1,887
2011-03-31 $-1,207
2010-12-31 $-935
2010-09-30 $-468
2010-06-30 $-245
2010-03-31 $-263
2009-12-31 $-246
2009-09-30 $-305
2009-06-30 $-331
2009-03-31 $-340
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00